| Paracrine regulation of the renal microcirculation LG Navar, EW Inscho, SA Majid, JD Imig, LM Harrison-Bernard, ... Physiological reviews 76 (2), 425-536, 1996 | 856 | 1996 |
| Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases JD Imig, BD Hammock Nature reviews Drug discovery 8 (10), 794-805, 2009 | 728 | 2009 |
| Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension JD Imig, X Zhao, JH Capdevila, C Morisseau, BD Hammock Hypertension 39 (2), 690-694, 2002 | 477 | 2002 |
| Epoxides and soluble epoxide hydrolase in cardiovascular physiology JD Imig Physiological reviews 92 (1), 101-130, 2012 | 440 | 2012 |
| Immune and inflammatory role in renal disease JD Imig, MJ Ryan Comprehensive Physiology 3 (2), 957, 2013 | 408 | 2013 |
| Angiotensin II hypertension is attenuated in interleukin-6 knockout mice DL Lee, LC Sturgis, H Labazi, JB Osborne Jr, C Fleming, JS Pollock, ... American Journal of Physiology-Heart and Circulatory Physiology 290 (3 …, 2006 | 323 | 2006 |
| Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles JD Imig, AP Zou, DE Stec, DR Harder, JR Falck, RJ Roman American Journal of Physiology-Regulatory, Integrative and Comparative …, 1996 | 309 | 1996 |
| An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension JD Imig, X Zhao, CZ Zaharis, JJ Olearczyk, DM Pollock, JW Newman, ... Hypertension 46 (4), 975-981, 2005 | 291 | 2005 |
| Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension VR Holla, F Adas, JD Imig, X Zhao, E Price Jr, N Olsen, WJ Kovacs, ... Proceedings of the National Academy of Sciences 98 (9), 5211-5216, 2001 | 284 | 2001 |
| Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage X Zhao, T Yamamoto, JW Newman, IH Kim, T Watanabe, BD Hammock, ... JOURNAL-AMERICAN SOCIETY OF NEPHROLOGY 15 (5), 1244-1253, 2004 | 278 | 2004 |
| Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases JD Imig American Journal of Physiology-Renal Physiology 289 (3), F496-F503, 2005 | 266 | 2005 |
| Intrarenal production of angiotensin II. LG Navar, JD Imig, L Zou, CT Wang Seminars in nephrology 17 (5), 412-422, 1997 | 249 | 1997 |
| Actions of epoxygenase metabolites on the preglomerular vasculature. JD Imig, LG Navar, RJ Roman, KK Reddy, JR Falck Journal of the American Society of Nephrology 7 (11), 2364-2370, 1996 | 242 | 1996 |
| Eicosanoid regulation of the renal vasculature JD Imig American Journal of Physiology-Renal Physiology 279 (6), F965-F981, 2000 | 239 | 2000 |
| Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II–infused rats LX Zou, JD Imig, AM Von Thun, A Hymel, H Ono, LG Navar Hypertension 28 (4), 669-677, 1996 | 229 | 1996 |
| Identification of a putative microvascular oxygen sensor DR Harder, J Narayanan, EK Birks, JF Liard, JD Imig, JH Lombard, ... Circulation research 79 (1), 54-61, 1996 | 225 | 1996 |
| Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow AP Zou, JD Imig, M Kaldunski, PR Ortiz de Montellano, Z Sui, RJ Roman American Journal of Physiology-Renal Physiology 266 (2), F275-F282, 1994 | 212 | 1994 |
| Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior EW Inscho, AK Cook, JD Imig, C Vial, RJ Evans The Journal of clinical investigation 112 (12), 1895-1905, 2003 | 198 | 2003 |
| Ang II Accumulation in Rat Renal Endosomes During Ang II-Induced Hypertension: Role of AT1 Receptor JL Zhuo, JD Imig, TG Hammond, S Orengo, E Benes, LG Navar Hypertension 39 (1), 116-121, 2002 | 195 | 2002 |
| Unraveling the mystery of Goldblatt hypertension LG Navar, L Zou, A Von Thun, C Tarng Wang, JD Imig, KD Mitchell Physiology 13 (4), 170-176, 1998 | 187 | 1998 |
